Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

Mark E. Cooper, Silvio E. Inzucchi, Bernard Zinman, Stefan Hantel, Maximilian von Eynatten, Christoph Wanner, Audrey Koitka-Weber

Research output: Contribution to journalLetterOtherpeer-review

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)713-715
Number of pages3
JournalAmerican Journal of Kidney Diseases
Issue number5
Publication statusPublished - Nov 2019

Cite this